Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription 13.05.2024 1 Aliment Pharmacol Ther 1 Am J Gastroenterol 3 Clin Gastroenterol Hepatol 6 Dis Colon Rectum 8 Gastroenterol Hepatol 2 Inflamm Bowel Dis 4 J Crohns Colitis 1 J Gastroenterol 2 Z Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. SONG S, Lv J, Li L, Pang Y, et al
   Editorial: Exploring the influence of diet on later-onset ulcerative colitis-Are eggs and spicy foods the key factors in Asia? Authors' reply.
   Aliment Pharmacol Ther. 2024;59:1453-1454.
   PubMed        
   
   

   
   Am J Gastroenterol

2. KARIME C, Black CN, Cortes P, Kwon JY, et al
   Utility of a Third Heplisav-B Dose in Patients with Inflammatory Bowel Disease without Immunity Following Two-Dose Heplisav-B Vaccination.
   Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002863.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

3. ROBLIN X, Moschetti E, Barrau M, Cheifetz AS, et al
   Risankizumab concentration but not IL-22 levels are associated with clinical and biochemical remission in patients with Crohn's disease.
   Clin Gastroenterol Hepatol. 2024 May 3:S1542-3565(24)00402.
   PubMed        
   
   
4. ALI S, Pasternak B, Moses J, Suskind DL, et al
   Characterization of Biologic Discontinuation Among Pediatric Patients with Crohn's Disease.
   Clin Gastroenterol Hepatol. 2024 May 7:S1542-3565(24)00406.
   PubMed         Abstract available
   
   
5. SANDS BE, D'Haens G, Panaccione R, Regueiro M, et al
   Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies.
   Clin Gastroenterol Hepatol. 2024 May 7:S1542-3565(24)00405.
   PubMed         Abstract available
   
   

   
   Dis Colon Rectum

6. KOTZE PG, Avellaneda N, Moretti RAM, Carvello M, et al
   Controversies in IPAA for Ulcerative Colitis: A Systematic Review of Different Anastomotic Techniques.
   Dis Colon Rectum. 2024;67.
   PubMed         Abstract available
   
   
7. MASPERO M, Hull TL
   State of the Art: Pouch Surgery in the 21st Century.
   Dis Colon Rectum. 2024;67.
   PubMed         Abstract available
   
   
8. SHEN B, Bruining DH, YunMa H
   Radiographic Evaluation of Ileal Pouch Disorders: A Systematic Review.
   Dis Colon Rectum. 2024;67.
   PubMed         Abstract available
   
   
9. NALLAPANENI P, Picoraro JA
   Diagnosis and Treatment of Pouch Disorders in Children: A Systematic Review.
   Dis Colon Rectum. 2024;67.
   PubMed         Abstract available
   
   
10. KO HM
    Histopathological Evaluation of Pouch Neoplasia in IBD and Familial Adenomatous Polyposis.
    Dis Colon Rectum. 2024;67.
    PubMed         Abstract available
    
    
11. SHEN B, Yao Q, Scherl EJ
    Management of Primary Sclerosing Cholangitis and Extraintestinal Disorders in Patients With Ileal Pouches: A Systematic Review.
    Dis Colon Rectum. 2024;67.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

12. FERRER CS, Gismero FM, Caballol B, Ballester MP, et al
    EFFICACY AND SAFETY OF BIOLOGICAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE IN ELDERLY PATIENTS: RESULTS FROM A GETECCU COHORT.
    Gastroenterol Hepatol. 2024 May 4:502197. doi: 10.1016/j.gastrohep.2024.502197.
    PubMed         Abstract available
    
    
13. FERNANDEZ-PEREZ FJ, Moreno NF, Lopez ES, Rodriguez-Gonzalez FJ, et al
    GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS (GMA) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A USEFUL THERAPEUTIC TOOL NOT JUST IN ULCERATIVE COLITIS BUT ALSO IN CROHN S DISEASE.
    Gastroenterol Hepatol. 2024 May 4:502196. doi: 10.1016/j.gastrohep.2024.502196.
    PubMed         Abstract available
    
    
14. RAMOS COZAR SN, Masot RM, Gallego BR, Rubio L, et al
    Assessment of the length of sick leave in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2024 May 5:502194. doi: 10.1016/j.gastrohep.2024.502194.
    PubMed         Abstract available
    
    
15. CALVO BERNAL MDM, Campos EP, Mota AA, Martinez AH, et al
    ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Gastroenterol Hepatol. 2024 May 6:502192. doi: 10.1016/j.gastrohep.2024.502192.
    PubMed         Abstract available
    
    
16. DA SILVA E SOUSA FI, Silva RL, Rabelo Lemos Filho CN, Pereira Santos MTO, et al
    VACCINE ADHERENCE AND ADVERSE EVENTS OF THE SARS-COV VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Gastroenterol Hepatol. 2024 May 7:502202. doi: 10.1016/j.gastrohep.2024.502202.
    PubMed         Abstract available
    
    
17. COSTA CA, Ferrer CS, Ramirez LG, Arranz EM, et al
    EVALUATION OF THE TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Gastroenterol Hepatol. 2024 May 7:502201. doi: 10.1016/j.gastrohep.2024.502201.
    PubMed         Abstract available
    
    
18. LAGO IR, Gros B, Sanchez K, Arumi D, et al
    Use of digital health tools in inflammatory bowel disease.
    Gastroenterol Hepatol. 2024 May 7:502200. doi: 10.1016/j.gastrohep.2024.502200.
    PubMed         Abstract available
    
    
19. GRAVINA AG, Pellegrino R, Palladino G, Imperio G, et al
    Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: a post-hoc patient-tailored analysis of the "BE-FIT-IBD" study**.
    Gastroenterol Hepatol. 2024 May 7:502203. doi: 10.1016/j.gastrohep.2024.502203.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

20. CHOI J, Wang Q, Beaton M, Kim RB, et al
    Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission.
    Inflamm Bowel Dis. 2024 May 8:izae097. doi: 10.1093.
    PubMed         Abstract available
    
    
21. BOURGONJE AR, Geertsema S, Holstein HJ, Bulthuis MLC, et al
    Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status.
    Inflamm Bowel Dis. 2024 May 4:izae102. doi: 10.1093.
    PubMed        
    
    

    
    J Crohns Colitis

22. POULSEN A, Rasmussen J, Wewer MD, Holm Hansen E, et al
    Re-resection Rates and Disease Recurrence in Crohn's Disease - A Population-Based Study Using Individual-Level Patient Data.
    J Crohns Colitis. 2024 May 10:jjae070. doi: 10.1093.
    PubMed         Abstract available
    
    
23. UKASHI O, Lahat A, Ungar B, Levy H, et al
    Pan-enteric Crohn's capsule (Eliakim) score reliability and responsiveness to change in active Crohn's disease.
    J Crohns Colitis. 2024 May 9:jjae068. doi: 10.1093.
    PubMed         Abstract available
    
    
24. LEIBOVITZH H, Sarbagili Shabat C, Hirsch A, Zittan E, et al
    Fecal transplantation for ulcerative colitis from diet conditioned donors followed by dietary intervention results in favorable gut microbial profile compared to fecal transplantation alone.
    J Crohns Colitis. 2024 May 9:jjae062. doi: 10.1093.
    PubMed         Abstract available
    
    
25. MUNIZ PEDROGO DA, Sears CL, Melia JMP
    Colorectal cancer in inflammatory bowel disease: a review of the role of gut microbiota and bacterial biofilms in disease pathogenesis.
    J Crohns Colitis. 2024 May 4:jjae061. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

26. CHIBA M, Kimura K
    Promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy.
    J Gastroenterol. 2024 May 4. doi: 10.1007/s00535-024-02111.
    PubMed        
    
    

    
    Z Gastroenterol

27. KUCHARZIK T, Dignass A, Atreya R, Bokemeyer B, et al
    [Not Available].
    Z Gastroenterol. 2024;62:769-858.
    PubMed        
    
    
28. LORENZ P, Dignass A, Kucharzik T, Jansen PL, et al
    [Not Available].
    Z Gastroenterol. 2024;62:e470-e476.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.